The long QT syndrome in pediatric age: Prognosis and risk factor

Minerva Cardioangiologica

Volumn 56, Issue 4, 2008, Pages 387-390

  Fazio, G ^a   Pipitone, S ^a   D'Angelo, L ^a   Di Gesaro, G ^a   Sutera, L ^a   Visconti, G ^a   Evola, G ^a   Novo, G ^a   Novo, S ^a  

^a NONE

Author keywords

Arrhythmias, cardiac; Death, sudden; Long QT syndrome

Indexed keywords

NADOLOL; PROPRANOLOL;

ADOLESCENT; ARTICLE; CAUSE OF DEATH; CHILD; CLINICAL ARTICLE; DISEASE DURATION; ELECTROCARDIOGRAM; FOLLOW UP; GENOTYPE; HEART ARRHYTHMIA; HOLTER MONITORING; HOSPITAL ADMISSION; HUMAN; ITALY; LONG QT SYNDROME; PROGNOSIS; RELATIVE; RISK FACTOR;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FOLLOW-UP STUDIES; HUMANS; INFANT; LONG QT SYNDROME; MUTATION; PROGNOSIS; RISK FACTORS;

EID: 52449107787     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Srivathsan K, Lester SJ, Appleton CP, Scott LR, Munger TM. Ventricular tachycardia in the absence of structural heart desease. Indian Pacing Electrophysiol J 2005;5:106-21
2. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 2006;48:e247-346.
3. Priori SG, Napolitano C, Schwartz PJ, Grillo M, Bloise R, Ronchetti E et al. Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers. JAMA 2004;292:1341-4.
4. Patel ND, Singh BK, Mathew ST. The heterogeneous spectrum of the long QT syndrome. Eur J Intern Med 2006;17:235-40.
5. Priori SG, Schwartz PJ, Napolitano C, Bloise R, Ronchetti E, Grillo M et al. Risk stratification in the long-QT sindrome. N Engl J Med 2003;348:1866-74.
6. Ellinor PT, Milan DJ, MacRae CA. Risk stratification in the long-QT syndrome. N Engl J Med 2003;349:908-9.
7. Goldenberg I, Mathew J, Moss AJ, McNitt S, Peterson DR, Zareba W et al. Corrected QT variability in serial electrocardiograms in long QT syndrome: the importance of the maximum corrected QT for risk stratification. J Am Coll Cardiol 2006;48:1047-52.
8. Locati ET. QT interval duration remains a major risk factor in long QT syndrome patients. J Am Coll Cardiol 2006;48:1053-5.
9. Cannom DS. Prevention of sudden cardiac death. J Cardiovasc Electrophysiol 2005;(16 Suppl 1):S21-4.
10. Villain E, Denjoy I, Lupoglazoff JM, Guicheney P, Hainque B, Lucet V et al. Low incidence of cardiac events with beta-blocking therapy in children with long QT syndrome. Eur Heart J 2004;25:1405-11.
11. Goel AK, Berger S, Pelech A, Dhala A. Implantable cardioverter defibrillator therapy in children with long QT syndrome. Pediatr Cardiol 2004;25:370-8.